AzTrials
AzTrials

Intubation; DifficultPhase 4NCT02190201

Comparison of McGrath and Macintosh Laryngoscope for DLT Intubation

A Phase 4 study testing videolaryngoscope and Direct laryngoscope in people with Intubation; Difficult and Thoracic Diseases, run by Huazhong University of Science and Technology at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators previous study showed that McGrath Series 5 videolaryngoscope is an alternative tool for double-lumen tube intubation. But it is not determined about the advantages and disadvantages of McGrath Series 5 videolaryngoscope for double-lumen tube intubation, compared with traditional Macintosh… Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
videolaryngoscope and Direct laryngoscope
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
1 siteChina
Study dates
Jul 2014to Nov 2014
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients
  • Thoracic surgery required one lung ventilation

Who cannot join

  • Difficult ventilation
  • Emergent operation

Trial locations and contacts

1 site in 1 country.

China1 site
  • Tongji Hospital, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030

Other trials in China

About this study

Official title: A Randomised Controlled Trial Comparing McGrath Series 5 Videolaryngoscope and Macintosh Laryngoscope for Double Lumen Tube Intubation

The investigators previous study showed that McGrath Series 5 videolaryngoscope is an alternative tool for double-lumen tube intubation. But it is not determined about the advantages and disadvantages of McGrath Series 5 videolaryngoscope for double-lumen tube intubation, compared with traditional Macintosh laryngoscope.

Read the detailed description

The investigators designed a randomised controlled study to compare of McGrath Series 5 videolaryngoscope and Macintosh laryngoscope for DLT intubation.

Being tested
videolaryngoscope, Direct laryngoscope
Keywords
videolaryngoscope, double lumen intubation
Medical subject headings
Thoracic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • videolaryngoscopeDevice

    Also called McGrath series 5 videolaryngoscope

    a kind of videolaryngoscopes, which are widely used in difficult airways.

  • Direct laryngoscopeDevice

    Also called Macintosh laryngoscopes

    A kind of traditional laryngoscopes

Study groups in NCT02190201
Study groupRoleWhat they receive
videolaryngoscopeExperimentalDLT intubation with McGrath videolaryngoscope
Receives: Device: videolaryngoscope
Direct laryngoscopeActive comparatorDLT intubation with Macintosh laryngoscope
Receives: Device: Direct laryngoscope

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubation time

    measured with a stopwatch, defined as time from inserting blade to mouth to withdrawal of blade

    Measured: at intubation

Secondary outcomes (1)
  1. number of successful intubation at first attempt

    Measured: at intubation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jul 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionNov 2014
  4. Study completionNov 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
114 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02190201
Sponsor's protocol ID
TJMZK201405001
Status last verified
Nov 2014
First submitted
10 Jul 2014
Last updated
21 Nov 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing videolaryngoscope and Direct laryngoscope in people with Intubation; Difficult and Thoracic Diseases, run by Huazhong University of Science and Technology at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Nov 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubation time (time frame: at intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Nov 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in